ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP17

Utilizing Support Networks to Improve Patient Outcomes

Brian Vogel, Lupus and Allied Diseases Association, Inc., San Diego, CA

Meeting: ACR Convergence 2023

Keywords: Community programs, Outcome measures, quality of life, Social support, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Patient Perspectives

Session Type: Patient Perspectives

Session Time: 4:00PM-5:00PM

Background/Purpose: In 2006, I realized I was gay and identified as LGBTQIA but did not come out. In 2008, I began experiencing chronic widespread pain, fatigue, and joint inflammation. I was referred to a rheumatologist due to a positive antinuclear antibody (ANA) test and misdiagnosed with juvenile rheumatoid arthritis. I began a medication regimen but no improvement. I consulted another rheumatologist and started a hydroxychloroquine (HCQ) and prednisone regimen. In 2010, I was diagnosed with Idiopathic Thrombocytopenia (ITP) and consulted with an oncologist when my platelets dropped dangerously low. After several failed intravenous immunoglobulin therapy (IVIG) infusions, I consulted a new oncologist and received a ten-week rituximab infusion treatment that raised my platelets. In 2011, I was formally diagnosed with Systemic Lupus Erythematosus (SLE). In 2013, I came out to my family and friends. I’ve tried numerous treatments between 2011-2022. SLE stabilized since February 2022 on current treatment.

Intervention: In 2017, my mom reached out to LADA and I volunteered at LADA’s Annual Lupus Charity Golf Classic. I met other people with lupus and other autoimmune diseases for the first time. I then participated in LADA’s Lupus Education Symposium. We learned a lot about the importance of clinical trials, patient empowerment, and care partnering from experts in the field. We then attended Annual Awareness Day at the State Capitol, as constituents of LADA, to meet with various legislators in the Senate and Assembly. I told my own story for the first time and shared my story with SLE. I will never forget the feeling of validation when seeing my story resonate with others. This feeling sparked a sense of empowerment and passion for advocating. I now share more on social media along with details of my story. When I moved to San Diego, I joined gay sports leagues to meet other gay men. It’s allowed me to make new friends and connections that are essential parts of my support networks. They significantly improve my SLE outcomes regarding my social, physical, and psychological well-being. Support networks became an essential component of coping with my SLE.

Maintenance: Through joining gay sports leagues, I’ve cultivated a tribe of friends in San Diego that are lifelong friends and connections. LADA has indeed steered me down a road to advocacy and self-empowerment as well as amplified my support networks. I’ve made lifelong friends and connections around the country that have become part of support network and certainly improved my outcomes coping with SLE. They’ve created a close-knit Lupus community that I can rely on when I need support and questions answered. In April 2020, I became LADA Board Member. I continue my advocacy efforts alongside LADA working with people with Lupus through raising my voice and sharing my journey.

Quality of Life: In 2013, I earned my Bachelor of Science degree. In November of 2020, I relocated to warmer climate and now live in San Diego. I’ve since changed careers and team of doctors. I’ve established strong healthy support networks in San Diego while maintaining LADA relationships. I’m eating healthier and exercising regularly. As a result of these things, I’m experiencing reduced disease activity and better quality of life.

Supporting image 1

My family at the 19th Annual Lupus Charity Golf Classic 2019

Supporting image 2

My care partner poodle “Charlie” and I

Supporting image 3

Our golf team “Don’t Drink and Drive”


Disclosures: B. Vogel: None.

To cite this abstract in AMA style:

Vogel B. Utilizing Support Networks to Improve Patient Outcomes [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/utilizing-support-networks-to-improve-patient-outcomes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utilizing-support-networks-to-improve-patient-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology